Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies to Improve Transplantation Outcomes
National Institutes of Health
Description
This grant encourages partnerships between transplant immunologists and gene editing specialists to use SCGE technology in transplants. The goal is to prevent rejection, achieve transplant tolerance, extend the lifespan of transplanted organs, and enhance their function. Studies should involve human tissues or animal models and include modifications that reduce immune response and improve transplant outcomes.
This Notice of Special Interest (NOSI) aims to stimulate multidisciplinary collaborations between transplant immunologists and gene editing experts to explore the use of SCGE technology in transplantation. The focus is on preventing or treating rejection, achieving transplant tolerance, prolongi…
Source
Grant ID
NOT-AI-24-085
Agency
National Institutes of Health
Subcategory/Subagency
National Institute of Allergy and Infectious Diseases
Key Dates
Opportunity Released
December 3, 2024
Similar opportunities
- Notice of Special Interest (NOSI): Development of Organotypic Culture Models for Transplantation Immunology Research
National Institutes of Health
- Notice of Special Interest (NOSI): Optimizing Vascularized Composite Allograft Survival
National Institutes of Health
- Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation (HCT)
National Institutes of Health
- Notice of Special Interest (NOSI): Pre-Clinical Research on Gene Therapies for Rare Genetic Neurodevelopmental Disorders
National Institutes of Health
- Notice of Funding Opportunity Purpose
National Institutes of Health